I am excited to be part of this community blog this year at the 22nd annual international ALS/MND research symposium in Sydney Australia. I landed saturday the 26th after making the 23 hour 46 minute trip from Boston, Massachusetts. This is my fourth symposium, having attended those held in Birmingham, England, Berlin, Germany and Orlando, USA. Each of them have had slight differences to their content and feel, and I am looking forward to seeing what this years event has to bring.
As the vice president of communications and public affairs for the ALS therapy development institute I am primarily here to gather information from the presentations and break out sessions for our research team back home. My secondary but equally important mission is to share information from the meetings with PALS and CALS worldwide via this blog, our blog (blogs.als.net) as well as twitter (@ALSTDI). As a non-scientist myself, I see the sessions here a little bit differently than most and hope that viewpoint is of interest and use to the ReCCoB readers. You will see me jumping from the preclinical to the clinical meetings with ease but usually pretty hurried as it is again a jam-packed schedule of talks, plenaries and poster sessions.
Finally, on closing this introduction, i would be remiss if i didn’t express how honored TDI is to be an official sponsor of the symposium, providing funding needed to provide all in attendance with free wireless Internet while at the symposium. I know that I will be using it to Tweet with hashtag #ALSSYMP.
Robert A. Goldstein
VP, Communications & Public Affairs
ALS Therapy Development Institute (USA)